Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03793738
Other study ID # 01004006344
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date December 2016
Est. completion date December 2023

Study information

Verified date October 2022
Source Tbilisi State Medical University
Contact Zaza Demetrashvili, MD, PhD
Phone +995599217733
Email zdemetr@yahoo.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study evaluates effect of anterior component separation and posterior component separation and transversus abdominis muscle release methods for treatment of midline ventral hernias.


Description:

The anterior component separation technique requires an extensive subcutaneous flap elevation, incision of the external oblique aponeurosis, and incision of the posterior rectus sheath. The posterior component separation technique utilized the retromuscular space, accessed by incising the posterior rectus sheath and dissecting the posterior sheath between the internal oblique and transversus abdominis muscles. Transversus abdominis muscle release dissected the posterior sheath back to the transversus abdominal muscle and accessed the space between muscle and trasversalis fascia.


Recruitment information / eligibility

Status Recruiting
Enrollment 40
Est. completion date December 2023
Est. primary completion date June 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - subject has midline ventral hernia - patient's approval to participate in the study Exclusion Criteria: - strangulated hernia - patient's preference for either operative technique - patient's refusal to participate in the study

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Anterior component separation

Posterior component separation


Locations

Country Name City State
Georgia Tbilisi State Medical University Tbilisi

Sponsors (1)

Lead Sponsor Collaborator
Zaza Demetrashvili

Country where clinical trial is conducted

Georgia, 

Outcome

Type Measure Description Time frame Safety issue
Primary Hernia recurrence Develop of ventral hernia recurrence during 3 year after surgery
Secondary Wound complications Develop of wound complications (seroma, hematoma, surgical site infection) 30 day after surgery